Page last updated: 2024-10-27

gabapentin and Paraplegia

gabapentin has been researched along with Paraplegia in 4 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Paraplegia: Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.

Research Excerpts

ExcerptRelevanceReference
" Right hemichorea developed and was related to adjunctive therapy with gabapentin."7.74Hemichorea associated with gabapentin therapy with hypoperfusion in contralateral basal ganglion - a case of a paraplegic patient with neuropathic pain. ( Chang, CC; Chang, ST; Lai, MH; Tsai, KC; Wang, TY, 2008)
"To present two years of experience in the use of gabapentin for the alleviation of neuropathic pain in spinal cord injury patients."7.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
" Right hemichorea developed and was related to adjunctive therapy with gabapentin."3.74Hemichorea associated with gabapentin therapy with hypoperfusion in contralateral basal ganglion - a case of a paraplegic patient with neuropathic pain. ( Chang, CC; Chang, ST; Lai, MH; Tsai, KC; Wang, TY, 2008)
"To present two years of experience in the use of gabapentin for the alleviation of neuropathic pain in spinal cord injury patients."3.71Gabapentin for neuropathic pain following spinal cord injury. ( Brown, DJ; Cooper, N; Frauman, AG; Hill, ST; Kirsa, SW; Lim, TC; To, TP, 2002)
"Sleep quality, chronotype, daytime sleepiness, neuropathic pain severity and interference were assessed based on questionnaires."1.51Actigraphy-based evaluation of sleep quality and physical activity in individuals with spinal cord injury. ( Albu, S; Forner-Cordero, A; Umemura, G, 2019)
"Robust allodynia was observed in all three ligation groups."1.42Ligation of mouse L4 and L5 spinal nerves produces robust allodynia without major motor function deficit. ( Baker, KB; Lanthorn, TH; Mason, S; Rajan, I; Savelieva, KV; Vogel, P; Ye, GL, 2015)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albu, S1
Umemura, G1
Forner-Cordero, A1
Ye, GL1
Savelieva, KV1
Vogel, P1
Baker, KB1
Mason, S1
Lanthorn, TH1
Rajan, I1
Lai, MH1
Wang, TY1
Chang, CC1
Tsai, KC1
Chang, ST1
To, TP1
Lim, TC1
Hill, ST1
Frauman, AG1
Cooper, N1
Kirsa, SW1
Brown, DJ1

Other Studies

4 other studies available for gabapentin and Paraplegia

ArticleYear
Actigraphy-based evaluation of sleep quality and physical activity in individuals with spinal cord injury.
    Spinal cord series and cases, 2019, Volume: 5

    Topics: Actigraphy; Adult; Analgesics; Benzodiazepines; Case-Control Studies; Exercise; Female; Gabapentin;

2019
Ligation of mouse L4 and L5 spinal nerves produces robust allodynia without major motor function deficit.
    Behavioural brain research, 2015, Jan-01, Volume: 276

    Topics: Amines; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Female; Gabapentin; gamma-Amin

2015
Hemichorea associated with gabapentin therapy with hypoperfusion in contralateral basal ganglion - a case of a paraplegic patient with neuropathic pain.
    Journal of clinical pharmacy and therapeutics, 2008, Volume: 33, Issue:1

    Topics: Adult; Amines; Analgesics; Basal Ganglia; Cerebrovascular Circulation; Chorea; Cyclohexanecarboxylic

2008
Gabapentin for neuropathic pain following spinal cord injury.
    Spinal cord, 2002, Volume: 40, Issue:6

    Topics: Acetates; Acute Disease; Adolescent; Adult; Aged; Amines; Chronic Disease; Cyclohexanecarboxylic Aci

2002